These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20848082)
1. Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis. Martins AK; Martins FS; Gomes DA; Elian SD; Vieira AT; Teixeira MM; Cara DC; Nardi RM; Nicoli JR Arch Microbiol; 2010 Dec; 192(12):995-1003. PubMed ID: 20848082 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Martins FS; Silva AA; Vieira AT; Barbosa FH; Arantes RM; Teixeira MM; Nicoli JR Arch Microbiol; 2009 Aug; 191(8):623-30. PubMed ID: 19526225 [TBL] [Abstract][Full Text] [Related]
3. Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice. Zacarías MF; Reinheimer J; Forzani L; Grangette C; Vinderola G Benef Microbes; 2014 Dec; 5(4):427-36. PubMed ID: 24902954 [TBL] [Abstract][Full Text] [Related]
4. Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice. Silva AM; Barbosa FH; Duarte R; Vieira LQ; Arantes RM; Nicoli JR J Appl Microbiol; 2004; 97(1):29-37. PubMed ID: 15186439 [TBL] [Abstract][Full Text] [Related]
5. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats. Salazar N; Binetti A; Gueimonde M; Alonso A; Garrido P; González del Rey C; González C; Ruas-Madiedo P; de los Reyes-Gavilán CG Int J Food Microbiol; 2011 Jan; 144(3):342-51. PubMed ID: 21078530 [TBL] [Abstract][Full Text] [Related]
6. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. Martins FS; Nardi RM; Arantes RM; Rosa CA; Neves MJ; Nicoli JR J Gen Appl Microbiol; 2005 Apr; 51(2):83-92. PubMed ID: 15942869 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice. Silva AM; Bambirra EA; Oliveira AL; Souza PP; Gomes DA; Vieira EC; Nicoli JR J Appl Microbiol; 1999 Feb; 86(2):331-6. PubMed ID: 10063632 [TBL] [Abstract][Full Text] [Related]
8. Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine. Splichalova A; Trebichavsky I; Rada V; Vlkova E; Sonnenborn U; Splichal I Clin Exp Immunol; 2011 Feb; 163(2):242-9. PubMed ID: 21155989 [TBL] [Abstract][Full Text] [Related]
9. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Shu Q; Lin H; Rutherfurd KJ; Fenwick SG; Prasad J; Gopal PK; Gill HS Microbiol Immunol; 2000; 44(4):213-22. PubMed ID: 10832963 [TBL] [Abstract][Full Text] [Related]
10. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice. Filho-Lima JV; Vieira EC; Nicoli JR J Appl Microbiol; 2000 Mar; 88(3):365-70. PubMed ID: 10747216 [TBL] [Abstract][Full Text] [Related]
11. Probiotic Bifidobacterium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia. Wei M; Wang Z; Liu H; Jiang H; Wang M; Liang S; Shi K; Feng J Nephrology (Carlton); 2014 Aug; 19(8):500-6. PubMed ID: 24787732 [TBL] [Abstract][Full Text] [Related]
12. Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. Martins FS; Rodrigues ACP; Tiago FCP; Penna FJ; Rosa CA; Arantes RME; Nardi RMD; Neves MJ; Nicoli JR J Med Microbiol; 2007 Mar; 56(Pt 3):352-359. PubMed ID: 17314366 [TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo. O'Mahony D; Murphy S; Boileau T; Park J; O'Brien F; Groeger D; Konieczna P; Ziegler M; Scully P; Shanahan F; Kiely B; O'Mahony L BMC Immunol; 2010 Dec; 11():63. PubMed ID: 21176205 [TBL] [Abstract][Full Text] [Related]
14. Influence of Technological Treatments on the Functionality of Bifidobacterium lactis INL1, a Breast Milk-Derived Probiotic. Zacarías MF; Souza TC; Zaburlín N; Carmona Cara D; Reinheimer J; Nicoli J; Vinderola G J Food Sci; 2017 Oct; 82(10):2462-2470. PubMed ID: 28892139 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the components of a commercial probiotic in gnotobiotic mice experimentally challenged with Salmonella enterica subsp. enterica ser. Typhimurium. Maia OB; Duarte R; Silva AM; Cara DC; Nicoli JR Vet Microbiol; 2001 Mar; 79(2):183-9. PubMed ID: 11230939 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the role and mechanism of Bifidobacterium animalis subsp. lactis isolated from neonates' feces in protecting neonatal rats from Salmonella infection. Lin Y; Xie Z; Li Z; Yuan C; Zhang C; Li Y; Xie K; Wang K Microb Pathog; 2023 Jan; 174():105935. PubMed ID: 36509312 [TBL] [Abstract][Full Text] [Related]
17. CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis subsp. lactis IN C57BL/6 MICE EXPERIMENTALLY INFECTED WITH Toxoplasma gondii. Ribeiro Cde M; Zorgi NE; Meireles LR; Garcia JL; Andrade Junior HF Rev Inst Med Trop Sao Paulo; 2016; 58():26. PubMed ID: 27074320 [TBL] [Abstract][Full Text] [Related]
18. Antagonistic effect exerted by three strictly anaerobic strains against various strains of Clostridium perfringens in gnotobiotic rodent intestines. Yurdusev N; Nicolas JL; Ladire M; Ducluzeau R; Raibaud P Can J Microbiol; 1987 Mar; 33(3):226-31. PubMed ID: 2882830 [TBL] [Abstract][Full Text] [Related]
19. [Bifidobacterium adolescentis suppresses the humoral immune response to an autochthonous intestinal bacterium--experiments with gnotobiotic rats]. Scharek L; Hartmann L; Heinevetter L; Blaut M Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):173-8. PubMed ID: 12058590 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of colonisation resistance in stool of human donors using ex vivo, in vitro and in vivo assays. Galvão MF; Bastos RW; Acurcio LB; Nascimento BB; Sandes SHC; Arantes RME; Souza MR; Martins FS; Vieira LQ; Nicoli JR Benef Microbes; 2017 Apr; 8(2):217-230. PubMed ID: 28116929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]